Back
Cytokinetics Stock Price Chart
Sponsored
CYTK
Sponsored
Elon Musk Predicts MAJOR Crisis in Trump's First Year
See Why Investors are Pouring Mountains of Cash into Certain Companies Trump Wants to Solve the Problem.
Sell
42
CYTK
Cytokinetics
Last Price:
$48.90
Seasonality Move:
7.19%
7 Day Trial
ALL ACCESS PASS
$
7
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CYTK is experiencing slight buying pressure.
Cytokinetics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 48.34 | Buy |
20-day SMA: | 49.94 | Sell |
50-day SMA: | 51.92 | Sell |
200-day SMA: | 57.02 | Sell |
8-day EMA: | 48.57 | Buy |
20-day EMA: | 49.65 | Sell |
50-day EMA: | 51.39 | Sell |
200-day EMA: | 54.32 | Sell |
Cytokinetics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.15 | Sell |
Relative Strength Index (14 RSI): | 44.96 | Sell |
Chaikin Money Flow: | 86391 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (48.36 - 51.52) | Sell |
Bollinger Bands (100): | (50.72 - 56.26) | Sell |
Cytokinetics Technical Analysis
Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Cytokinetics Stock
Is Cytokinetics Stock a Buy?
-
Cytokinetics share price is 48.95 while CYTK 8-day simple moving average is 48.34, which is a Buy signal.
-
The stock price of CYTK is 48.95 while Cytokinetics 20-day SMA is 49.94, which makes it a Sell.
-
Cytokinetics 50-day simple moving average is 51.92 while CYTK share price is 48.95, making it a Sell technically.
-
CYTK stock price is 48.95 and Cytokinetics 200-day simple moving average is 57.02, creating a Sell signal.
CYTK Technical Analysis vs Fundamental Analysis
Sell
42
Cytokinetics (CYTK)
is a Sell
Is Cytokinetics a Buy or a Sell?
-
Cytokinetics stock is rated a SellThe current Cytokinetics [CYTK] share price is $48.95. The Score for CYTK is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
Cytokinetics Stock Info
Market Cap:
5.8B
Price in USD:
48.95
Share Volume:
1M
Cytokinetics 52-Week Range
52-Week High:
110.25
52-Week Low:
43.21
Sell
42
Cytokinetics (CYTK)
is a Sell
Cytokinetics Share Price Forecast
-
What is the Cytokinetics stock price today?The Cytokinetics stock price is 48.95 USD today.
-
Will CYTK stock go up or go down?Cytokinetics> share price is forecast to RISE/FALL based on technical indicators
-
Is Cytokinetics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Cytokinetics is overvalued.
Is Cytokinetics Stock a Buy?
-
Cytokinetics share price is 48.95 while CYTK 8-day exponential moving average is 48.57, which is a Buy signal.
-
The stock price of CYTK is 48.95 while Cytokinetics 20-day EMA is 49.65, which makes it a Sell.
-
Cytokinetics 50-day exponential moving average is 51.39 while CYTK share price is 48.95, making it a Sell technically.
-
CYTK stock price is 48.95 and Cytokinetics 200-day simple moving average is 54.32, creating a Sell signal.
Fundamental Analysis of Cytokinetics
Is Cytokinetics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.26 per share, and an increase next year of $0.06 per share.
Technical Analysis of Cytokinetics
Should I short Cytokinetics stock?
-
CYTK Moving Average Covergence Divergence (MACD) indicator is -1.15, suggesting Cytokinetics is a Sell
-
Cytokinetics Relative Strength Index (RSI) is 44.96, which suggest Cytokinetics is oversold
-
The Bollinger Bands (25) for Cytokinetics is (48.36 - 51.52), which suggest Cytokinetics is a Sell
-
The Bollinger Bands (100) for Cytokinetics is (50.72 - 56.26), which suggest Cytokinetics is a Sell
* Cytokinetics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.